Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Arteaga

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Reumatologia Clinica|December 27, 2017
Perceptions of patients with rheumatic diseases treated with subcutaneous biologicals on their level of information: RHEU-LIFE SurveyJavier de Toro, Luis Cea-Calvo, Enrique Battle, et al.
Musculoskeletal Care|August 26, 2020
Patients' perceptions on shared decision making during prescription of subcutaneous biological drug treatments for inflammatory arthritis: The RHEU-LIFE surveyJavier de Toro, Carlos M González, Luis Cea-Calvo, et al.
Cirugia Espanola|June 8, 2007
[Localization of gastrointestinal bleeding from jejunal diverticuli by methylene blue dye]Yaiza Hernández Piñero, Antonio I Martín Malagón, Francisco Díaz Romero, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The interferon response signature links to increased expression of transposable elements in neutrophils of systemic lupus erythematosus patientsLeo J Arteaga-Vazquez, Hugo Sepulveda, Bruno Villalobos, et al.
Scandinavian Journal of Immunology|November 25, 2005
Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokinesH J Arteaga, A J Mohamed, B Christensson, et al.
Patient Preference and Adherence|August 10, 2017
Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological productsCarlos M González, Loreto Carmona, Javier de Toro, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Clinical implications of the presence of refractile particles in the liver of haemodialysis patientsJ M Morales, F Colina, J Arteaga, et al.
Medicine|March 31, 2021
Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective studyJuan J Alegre-Sancho, Xavier Juanola, José M Rodríguez-Heredia, et al.
Obesity Surgery|August 20, 2018
Bariatric Surgery Waiting Lists in SpainI J Arteaga-González, A I Martín-Malagón, J C Ruiz de Adana, et al.
Rheumatology International|July 1, 2018
The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concernLuis Cea-Calvo, Enrique Raya, Carlos Marras, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Reumatologia Clinica|December 27, 2017
Perceptions of patients with rheumatic diseases treated with subcutaneous biologicals on their level of information: RHEU-LIFE SurveyJavier de Toro, Luis Cea-Calvo, Enrique Battle, et al.
Musculoskeletal Care|August 26, 2020
Patients' perceptions on shared decision making during prescription of subcutaneous biological drug treatments for inflammatory arthritis: The RHEU-LIFE surveyJavier de Toro, Carlos M González, Luis Cea-Calvo, et al.
Cirugia Espanola|June 8, 2007
[Localization of gastrointestinal bleeding from jejunal diverticuli by methylene blue dye]Yaiza Hernández Piñero, Antonio I Martín Malagón, Francisco Díaz Romero, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
The interferon response signature links to increased expression of transposable elements in neutrophils of systemic lupus erythematosus patientsLeo J Arteaga-Vazquez, Hugo Sepulveda, Bruno Villalobos, et al.
Scandinavian Journal of Immunology|November 25, 2005
Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokinesH J Arteaga, A J Mohamed, B Christensson, et al.
Patient Preference and Adherence|August 10, 2017
Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological productsCarlos M González, Loreto Carmona, Javier de Toro, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Clinical implications of the presence of refractile particles in the liver of haemodialysis patientsJ M Morales, F Colina, J Arteaga, et al.
Medicine|March 31, 2021
Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective studyJuan J Alegre-Sancho, Xavier Juanola, José M Rodríguez-Heredia, et al.
Obesity Surgery|August 20, 2018
Bariatric Surgery Waiting Lists in SpainI J Arteaga-González, A I Martín-Malagón, J C Ruiz de Adana, et al.
Rheumatology International|July 1, 2018
The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concernLuis Cea-Calvo, Enrique Raya, Carlos Marras, et al.
Pageof 6